결핵노출접촉자감염관리 서울아산병원감염내과 김성한

Similar documents
TB Prevention Who and How to Screen

LTBI: Who to Test & When to Treat

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

New Standards for an Old Disease:

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Contact Investigation

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

Contracts Carla Chee, MHS May 8, 2012

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Interpretation of TST & IGRA results. Objectives

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

TUBERCULOSIS CONTACT INVESTIGATION

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

INDEX CASE INFORMATION

Nguyen Van Hung (NTP, Viet Nam)

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

CHAPTER 3: DEFINITION OF TERMS

Fundamentals of Tuberculosis (TB)

TUBERCULOSIS. Pathogenesis and Transmission

At the end of this session, participants will be able to:

TB in Corrections Phoenix, Arizona

AT HIGH RISK OF PROGRESSING TO ACTIVE TB? Senior Lecturer and Consultant Physician University Hospitals of Leicester UK

Approaches to LTBI Diagnosis

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

결핵 전남대학교병원 호흡기내과 권용수

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

Diagnosis and Medical Management of Latent TB Infection

TB in Corrections Phoenix, Arizona

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

TB Contact Investigation

ATS/CDC Guidelines for Treating Latent TB Infection

Latent TB Infection (LTBI)

TB Contact Investigation Basics

Contact Investigation San Antonio, Texas January 14-15, 2013

TB Intensive San Antonio, Texas

Therapy for Latent Tuberculosis Infection

TB Update: March 2012

Evidence-based use of the new diagnostic tools for TB-infection

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

Programmatic management of LTBI : a two pronged approach for ending the TB epidemic. Haileyesus Getahun Global TB Programme WHO/HQ

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Communicable Disease Control Manual Chapter 4: Tuberculosis

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

What s New in TB Infection Control?

Screening for Tuberculosis Infection. Harlingen, TX. Linda Dooley, MD has the following disclosures to make:

Diagnosis of Tuberculosis Infection and Disease

TB Intensive. San San Antonio, Texas. December 1-3, 2010

Tuberculosis Populations at Risk

Tuberculosis Update. Topics to be Addressed

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

TB Intensive San Antonio, Texas August 7-10, 2012

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

2018 Tuberculosis Clinical Intensive: Infection Prevention & Control. > No disclosures

TB Nurse Case Management San Antonio, Texas March 7 9, Clinical Diagnosis and

TB Intensive Tyler, Texas December 2-4, 2008

Self-Study Modules on Tuberculosis

TB Intensive San Antonio, Texas November 11 14, 2014

Contact Investigation and Prevention in the USA

ESCMID Online Lecture Library. by author

Peggy Leslie-Smith, RN

Role of the Laboratory in TB Diagnosis and Management

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Conflict of Interest Disclosures:

TUBERCULOSIS CONTACT INVESTIGATION

TB Intensive Houston, Texas October 15-17, 2013

Coordinating with Public Health on Tuberculosis Testing & Treatment

Tuberculosis: Where Are We Now?

Making the Diagnosis of Tuberculosis

Chapter 5 Treatment for Latent Tuberculosis Infection

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Using Interferon Gamma Release Assays for Diagnosis of TB Infection

Detecting latent tuberculosis using interferon gamma release assays (IGRA)

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease

Diagnosis and Management of Latent TB Infection Douglas Hornick, MD September 27, 2011

What Is New in Combination TB Prevention? Lisa J. Nelson Treatment and Care (TAC) Team HIV Department WHO HQ

has the following disclosures to make:

Primary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

Ongoing Research on LTBI and Research priorities in India

Tuberculosis Education for the Medical Professional

Diagnosis and Medical Case Management of Latent TB. Bryan Rock, MD April 27, 2010

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents

Diagnosis Latent Tuberculosis. Disclosures. Case

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

Thorax Online First, published on December 8, 2009 as /thx

TB Classification (ATS/CDC)

TB Intensive San Antonio, Texas December 1-3, 2010

TB Nurse Case Management Davenport, Iowa September 27 28, 2011

TB Intensive San Antonio, Texas

TB Infection Control: Fears and Facts Lisa V. Adams, MD Elizabeth A. Talbot, MD Dartmouth Medical School June 2011

TB Intensive Houston, Texas October 15-17, 2013

The Most Widely Misunderstood Test of All

Transcription:

결핵노출접촉자감염관리 서울아산병원감염내과 김성한

TB incidence (2012) TB incidence South Korea 108 China 73 Taiwan 68 Portucal 26 Japan 19 Spain 14 US 3.6 * unit- per 100,000 population Adapted from WHO

Adapted from WHO

Emerg Infect Dis 2015;21:1913-20

Emerg Infect Dis 2015;21:1913-20

Reasons for not-declining TB High prevalence of LTBI in elderly population Increasing population with DM High smoking rate Inadequate patient management Immigrants from high-burden countries Emerg Infect Dis 2015;21:1913-20

Exposure to contacts 1. Intensity 2. Duration No infection (50%) Infection (25-50%) CMI No disease (90%) Disease (10%) Early progressive (5%) Late recrudescent (5%) Primary progressive TB Postprimary TB Reactivation TB

Factors for the TB transmission The characteristics of the index patient smear positivity, cavity, cough The characteristics of the contact children < 5 years immunocompromised The feature of exposure time spent with the index patient degree and duration of proximity characteristics of the place

Factors for the TB transmission The characteristics of the index patient smear positivity, cavity, cough The characteristics of the contact children < 5 years immunocompromised The feature of exposure time spent with the index patient degree and duration of proximity characteristics of the place

1574 culture-positive TB in SF DNA fingerprints for 1359 (86%) Of 71 clusters of matching fingerprints, 28 (39%) had a smear-negative TB 183 secondary cases in these 71 clusters, of whom 32 (17% [95% CI 16-32%]) were attributed to infection by smear-negative

551 (98%) of 561 patients with smearpositive TB 123 (73%) of 171 patients with smearnegative TB

Smear-negative TB 결론 Smear-negative TB 의경우전파가덜되기는하지만전체결핵전파의최소 20% 를차지한다 격리필요 Smear-negative TB 의 3/4 은 Xpert TB/RIF 검사로 detection 할수있다 적극적인검사필요

5 세미만 Int J Tuberc Lung Dis 1997;1:38-43 South Africa > 98% BCG vccination Of 155 children under 5 years of age in contact with 80 index cases 14% infected, 34% diseased, 52% not infected Of 154 household members over 5 years 21% diseased

HIV 100 배이식 50 배투석 20 배 최근접촉 15 배 Old TB lesion 10 배 스테로이드 5 배 TNF blocker 3 배 DM 2-3 배 담배 2-3 배

Contact investigations Infectious period AFB (+): 3 months before airborne precaution or persistent AFB (-) AFB (-): 1 month before airborne precaution Exposure intensity Infectiousness of index case Presence or absence of risk procedure Proximity: a shared airspace Overlap with infectious period Duration of exposure: 4 hours, 8 hours, 100 hours? Presence or absence of PPE

Household vs casual contact Household contact Those who lived in the same house as the index patient Casual contact Those who did not live in the same house as the index patient; these were mostly family, workplace and school contacts Eur Respir J 2013;41:758-60

Size of exposure site Small- < 20 m 2 (car, bedroom, living room or office) Large- 20 m 2 (restaurant) Eur Respir J 2013;41:758-60

Exposure sites With ventilation- with windows Without ventilation- without windows Eur Respir J 2013;41:758-60

Importance of household contact Eur Respir J 2013;41:758-60

Brazil, close contact definition changed > 100 hours in total before 2005 Active TB 2% (16/810) LTBI 62% (496/794) > 4 hours a week since 2005 according to TB Trial Consortium Active TB 2.7% (35/1310) LTBI 69% (877/1275) NN to screen (contact/new case) 50 37 NN to contact trace (index case/new case) 16 10

Contact tracing 결론 Household contact 은감염이잘되지만, casual contact 은감염이덜된다 5 세미만및면역저하환자는감염이잘된다 Duration of exposure 등은 recall bias 등으로부정확할가능성이높다 주당 4 시간을많이사용 감염이발생한상황 (household, prison, aerosol procedure) 이더좋은지표이다

Priorities for contact investigation Case characteristics Susceptibility and vulnerability of contacts (contact risk factors) Circumstances of the exposures (exposure environment) MMWR 2015;54:RR-15

Case characteristics High-priority cases Pulmonary, laryngeal, or pleural TB with AFB (+) and/or cavity Medium-priority cases Pulmonary, laryngeal or pleural TB with AFB (-) and/or non-cavity Low-priority cases Extrapulmonary TB MMWR 2015;54:RR-15

Contact risk factors HIV Household contacts Contacts in congregated settings < 5 years old Certain medical procedure Certain medical risk factors (DM, silicosis, gastrectomy ) * medium-priority: 5-14 years old MMWR 2015;54:RR-15

Exposure environment High-priority contacts > 8 hours in a small poorly ventilated space > 16 hours in a small well ventilated space > 24 hours in a classroom size space > 100 hours in a large open space Medium-priority contacts > 4 hours in a small poorly ventilated space > 8 hours in a small well ventilated space > 12 hours in a classroom size space > 50 hours in a large open space MMWR 2015;54:RR-15

High-priority contacts > 8 hours in a small poorly ventilated space > 16 hours in a small well ventilated space > 24 hours in a classroom size space > 100 hours in a large open space Medium-priority contacts > 4 hours in a small poorly ventilated space > 8 hours in a small well ventilated space > 12 hours in a classroom size space > 50 hours in a large open space MMWR 2015;54:RR-15

High-priority contacts > 8 hours in a small poorly ventilated space > 16 hours in a small well ventilated space > 24 hours in a classroom size space > 100 hours in a large open space Medium-priority contacts > 4 hours in a small poorly ventilated space > 8 hours in a small well ventilated space > 12 hours in a classroom size space > 50 hours in a large open space MMWR 2015;54:RR-15

MMWR 2015;54:RR-15

High- and medium-priority contacts MMWR 2015;54:RR-15

Previous TST (+) MMWR 2015;54:RR-15

활동성결핵및잠복결핵진단 전통적인방법 - 결핵피부반응검사 새로운방법 (2000 년대중반이후 )- TB IGRA

Gene difference between M. TB and NTM M. bovis (BCG strain) Most NTM RD1 RD2.RD16 M. tuberculosis ESAT-6 CFP-10 Potent T-cell antigens

Lalvani A, et al. Curr Opinion Infect Dis 2007;20:264-71

TTT (targeted tuberculin test) > 5 mm > 10 mm > 15 mm HIV Other conditions All others Recent contacts CXR c/w old TB Conferring inc. risk From an edemic area IDU Employees of high risk TB lab personnel 2000 ATS guideline

18~20 years observational study after TST (n=82,269) Induration size of TST No. of cases Average annual rate Age (years) Age (years) 1-6 7-12 13-18 total 1-6 7-12 13-18 total 16 mm 79 70 73 160 238 123 149 160 11-15 mm 22 21 16 98 186 89 65 98 6-10 mm 11 14 13 46 59 40 44 45 Comstock GW, et al. Am J Epidemiol 1974:99:131-8

Landmark longitudinal study Diel R, et al. AJRCCM 2008;177:1164-70 - 601 recent contact persons with active TB for 2 years F/U 6 TB development Diel R, et al. AJRCCM 2011;183:88-95 - 1033 recent contact persons with active TB for 4 years F/U 19 TB development - QFT (+) without INH tx 13% (19/158) TB - TST ( 5 mm) without INH tx 3% (17/555) TB - TST ( 10 mm) without INH tx 5% (10/207) TB

Landmark HCW study Dorman, et al. AJRCCM 2014;189:77-87 - 2,563 HCW in US - TST, QFT, T-SPOT baseline and every 6 months for 18 months - (+) 5% by TST, 0.9% conversion - (+) 5% by QFT, 6% conversion - (+) 6% by T-SPOT, 8% conversion - About ¾ of converter became negative when retested 6 months later false-positive d/t short- and long-term variability

김성한등 Am J Transplant 2011;11:1927-35

이유미, 김성한등 J Infect 2014;69:165-73

김성한등 J Antimicrob Chemother 2015;70:1567-72

김성한등 J Antimicrob Chemother 2015;70:1567-72

IGRA in LTBI Recent contact (recommended) - Recent infection (intimate contact) Health care workers (not recommended) - Recent infection (intimate contact) vs insignificant infection (casual contact) Immunocompromised patients (?) - Remote infection reactivation

Recent HCW study King, et al. AJRCCM 2015;192:367-73 - 42,155 T-SPOT from 16,076 HCW in US - Mean conversion rate 0.8% (0.0%-2.5%) - Mean reversion rate 17.6% - T-SPOT as reliable as TST in serial testing

증례 1 장 O 록 M/71 세 - 2015년 12월 18일 KT - 2016년 2월 8일기침을주소로응급실내원 - 홍O인전공의가 5분가량문진과청진 * ER 홍O인전공의 : AFB (-) and non-cavitary CXR? IGRA? TST?

MMWR 2015;54:RR-15

High- and medium-priority contacts

증례 1 장 O 록 M/71 세 - 2015년 12월 18일 KT - 2016년 2월 8일기침을주소로응급실내원 - 홍O인전공의가 5분가량문진과청진 * ER 홍O인전공의 : AFB (-) and non-cavitary 증상있으면 CT 촬영해야함 CXR TST (not done) TST 8 weeks later (IGRA 8 weeks later?)

증례 2 김 O 균 M/47 세 - 2013 년 7 월 KT - 당시 IGRA (+) INH 9 months - 2016 년 3 월초같이사는어머니가 AFB (+) and non-cavitary TB 진단 - CXR normal - 2016 년 4 월 IGRA (+) retreatment?

Previous TST (+)